Adipose-Derived Orthobiologics and Extracellular Vesicles in Foot and Ankle Surgery: Current Evidence and Clinical Limitations
Foot & Ankle Specialist · 2026-12 · 19 (3_suppl)
DOI: 10.1177/19386400261497293 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Foot & Ankle Specialist, online erschienen am 12.10.2026. Verfasst von Alexander Tham und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, NYU Langone Health, New York City, New York. Hauptthemen laut MEDLINE: Extracellular Vesicles, Adipose Tissue, Foot, Ankle. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
Interest in adipose-derived orthobiologics and extracellular vesicles (EVs) has expanded as clinicians seek minimally invasive treatments for musculoskeletal disorders. However, culture-expanded adipose-derived stromal cells, stromal vascular fraction, microfragmented adipose tissue (MFAT), and isolated EVs are biologically and regulatorily distinct products. This narrative review summarizes their biological rationale, processing, clinical evidence, regulatory considerations, and potential application in foot and ankle surgery. Randomized studies in knee osteoarthritis suggest that MFAT may provide symptomatic improvement, but it has not consistently demonstrated superiority over other orthobiologic injections, and the certainty of evidence remains low. Preclinical EV studies provide biological plausibility for effects on tendon healing, tendon-to-bone integration, and cartilage repair. However, substantial heterogeneity in cellular source, preparation, dose, and experimental model limits translation. Human orthopaedic EV evidence remains confined to early studies in knee osteoarthritis using placental or umbilical cord derived products, with limited and conflicting evidence of efficacy and no completed studies specific to the foot and ankle. No adipose-derived regenerative medicine or EV product is Food and Drug Administration-approved for an orthopaedic indication. Current evidence therefore does not support routine clinical use or claims of tissue regeneration. Standardized product characterization and well-designed comparative trials are required to establish safety, efficacy, and appropriate clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, NYU Langone Health, New York City, New York.
- Albany Medical Center, New York City, New York.
ORCID-Profile: Alexander Tham, John G Kennedy
Zitieren
APA
Tham, A., Rubin, J., Butler, J. J., Montgomery, S. R., Mercer, N. P., Lezak, B. A., Mojica, E., Charalambous, L., & Kennedy, J. G. (2026). Adipose-Derived Orthobiologics and Extracellular Vesicles in Foot and Ankle Surgery: Current Evidence and Clinical Limitations. Foot & Ankle Specialist, 19(3_suppl). https://doi.org/10.1177/19386400261497293
Vancouver
Tham A, Rubin J, Butler JJ, Montgomery SR, Mercer NP, Lezak BA, et al. Adipose-Derived Orthobiologics and Extracellular Vesicles in Foot and Ankle Surgery: Current Evidence and Clinical Limitations. Foot & Ankle Specialist. 2026;19(3_suppl). doi:10.1177/19386400261497293
BibTeX
@article{Tham2026,
author = {Tham, Alexander and Rubin, Jared and Butler, James J and Montgomery, Samuel R and Mercer, Nathaniel P and Lezak, Bradley A and Mojica, Edward and Charalambous, Lefko and Kennedy, John G},
title = {Adipose-Derived Orthobiologics and Extracellular Vesicles in Foot and Ankle Surgery: Current Evidence and Clinical Limitations},
journal = {Foot & Ankle Specialist},
year = {2026},
volume = {19},
number = {3_suppl},
doi = {10.1177/19386400261497293}
}
EUVIMED